MUFG Securities EMEA’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
MUFG Securities EMEA's BMY Position: Q2 2026 in Review
MUFG Securities EMEA reduced its Bristol-Myers Squibb (BMY) stake by 4.2% in Q2 2026, selling an estimated $203K and leaving 79,928 shares worth $4.61M. The position accounts for 0.05% of the portfolio, ranked #218.
MUFG Securities EMEA first reported a position in BMY in Q4 2017 and has held it in 18 quarters since. The position peaked at $158M in Q1 2019. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- MUFG Securities EMEA held 79,928 shares of Bristol-Myers Squibb worth $4.61M as of Q2 2026.
- MUFG Securities EMEA sold 3,543 Bristol-Myers Squibb shares in Q2 2026, an estimated $203K.
- Bristol-Myers Squibb made up 0.05% of MUFG Securities EMEA's portfolio in Q2 2026, its #218 holding.
- MUFG Securities EMEA first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 18 quarters since.
- MUFG Securities EMEA's Bristol-Myers Squibb position peaked at $158M in Q1 2019.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.